LivaNova PLC
NASDAQ:LIVN
Relative Value
The Relative Value of one LIVN stock under the Base Case scenario is 103.83 USD. Compared to the current market price of 52.76 USD, LivaNova PLC is Undervalued by 49%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
LIVN Competitors Multiples
LivaNova PLC Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
UK |
LivaNova PLC
NASDAQ:LIVN
|
2.8B USD | 2.5 | 162.4 | 28.7 | 52.9 | ||
US |
Abbott Laboratories
NYSE:ABT
|
184.8B USD | 4.6 | 32.3 | 19.2 | 28.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
130.8B USD | 18.4 | 72.8 | 56.1 | 70.5 | ||
US |
Stryker Corp
NYSE:SYK
|
123.8B USD | 6 | 39.1 | 24.4 | 30.2 | ||
IE |
Medtronic PLC
NYSE:MDT
|
105.5B USD | 3.3 | 25.1 | 13.4 | 19 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
98.5B USD | 6.9 | 62.7 | 29.3 | 43.7 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 3.5 | 55.7 | 18.7 | 39.4 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
56.8B EUR | 2.6 | 37.4 | 18 | 30.4 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.5B USD | 8.6 | 36.7 | 26.6 | 28.8 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.4B USD | 13.9 | 93.1 | 62.7 | 81.7 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
328.2B CNY | 9.5 | 28.9 | 25 | 25 |